Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 36,434 | 34,431 | 34,105 | 28,429 | 25,086 |
| Operating Income | -36,434 | -34,431 | -34,105 | -28,429 | -25,086 |
| Other Income | 4,614 | 4,848 | 3,828 | 3,855 | 4,087 |
| Pre-tax Income | -31,820 | -29,583 | -30,277 | -24,574 | -20,999 |
| Net Income Continuous | -31,820 | -29,583 | -30,277 | -24,574 | -20,999 |
| Net Income | $-31,820 | $-29,583 | $-30,277 | $-24,574 | $-20,999 |
| EPS Basic Total Ops | -0.48 | -0.44 | -0.55 | -0.46 | -0.40 |
| EPS Basic Continuous Ops | -0.58 | -0.54 | -0.69 | -0.58 | -0.50 |
| EPS Diluted Total Ops | -0.48 | -0.44 | -0.55 | -0.46 | -0.40 |
| EPS Diluted Continuous Ops | -0.58 | -0.54 | -0.69 | -0.58 | -0.50 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.45 | -0.55 | -0.46 | -0.40 |
| EBITDA(a) | $-36,837 | $-35,066 | $-35,125 | $-29,913 | $-26,867 |